But this is not that situation. These are companies that make a large volume, and they make it not on receipt of a prescription.
Michael Burgess: “But this is not that situation. These are companies that make a large volume, and they make it not on receipt of a…”
Editor's note · Context
Burgess distinguishes between small pharmacies and larger companies producing medications.
Share
More from Michael Burgess
I urge all my fellow colleagues to join me in supporting H.R. 766 and ensuring that we continue to prioritize preventive healthcare initiatives for the betterment of all Americans, and I reserve the balance of my time.
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I am pleased to yield 4 minutes to the gentleman from Missouri (Mr. Alford) for his comments.
This has all been so moving and so lovely, but if anyone tuned in late tonight in C-SPAN, they probably thought I passed because it really did sound like a eulogy. I am still here, and I will continue to text and call and inform everyone…





